Cognitive Therapy for Personality Disorders

2012 ◽  
pp. 726-750
Author(s):  
Robert L. Leahy ◽  
Lata K. McGinn
Keyword(s):  
Personality Disorders ◽  
Cognitive Therapy ◽  
Dialectical Behavior Therapy ◽  
Negative Impact ◽  
Cognitive Model ◽  
Theoretical Models ◽  
Axis I Disorders ◽  
Treatment Research ◽  
Axis I ◽  
Schema Model

Personality disorders are prevalent and common among patients presenting for treatment. Research suggests that personality disorders are associated with significant impairment and can exert a negative impact on psychological and pharmacological treatments for Axis I disorders. Despite this, treatment development and research for personality disorders has lagged behind those of Axis I disorders. The present chapter describes two major cognitive models of personality disorder—the cognitive model advanced by Beck, Freeman, and colleagues and the schema model advanced by Young and colleagues (a brief review of the dialectical behavior therapy model is also provided). The chapter presents research on both theoretical models and outlines similarities and differences between the two theoretical formulations. A description of the therapeutic relationship in cognitive therapy is also provided. The components of treatment are presented followed by a case example for purposes of illustration. Finally, the chapter summarizes the extant research on the treatment of personality disorders. Although the data are encouraging, suggesting that personality disorders are responsive to treatment, further controlled trials are still needed.

Associations of Parental Personality Disorders and Axis I Disorders with Childrearing Behavior

Psychiatry ◽  
2006 ◽  
Vol 69 (4) ◽  
pp. 336-350 ◽  
Author(s):  
Jeffrey G. Johnson ◽  
Patricia Cohen ◽  
Stephanie Kasen ◽  
Miriam K. Ehrensaft ◽  
Thomas N. Crawford
Keyword(s):  
Personality Disorders ◽  
Axis I Disorders ◽  
Axis I ◽  
Parental Personality

Cognitive Therapy for Comorbid Depression

2014 ◽  
Author(s):  
Mark A. Whisman ◽  
Daniel BE
Keyword(s):  
Substance Use ◽  
Anxiety Disorders ◽  
Personality Disorders ◽  
Cognitive Therapy ◽  
Substance Use Disorders ◽  
Clinical Guidelines ◽  
Clinical Samples ◽  
Comorbid Depression ◽  
Axis Ii ◽  
Axis I

Depression often co-occurs with other Axis I and Axis II psychiatric disorders. This chapter presents a model for how cognitive therapy (CT) of depression can be adapted in conceptualizing and treating the complex set of issues and problems that often accompany comorbid depression. It begins with a discussion of the prevalence of comorbidity in community and clinical samples, then review the research on comorbidity and outcome to CT for depression, followed by a model for adapting or modifying CT for patients who present with depression and a comorbid Axis I or Axis II disorder. The chapter concludes with specific clinical guidelines for treating depression that co-occurs with anxiety disorders, substance use disorders, and personality disorders.

scholarly journals Personality disorder and impaired functioning from adolescence to adulthood

2007 ◽  
Vol 190 (5) ◽  
pp. 415-420 ◽  
Author(s):  
Andrew E. Skodol ◽  
Jeffrey G. Johnson ◽  
Patricia Cohen ◽  
Joel R. Sneed ◽  
Thomas N. Crawford
Keyword(s):  
Personality Disorder ◽  
Personality Disorders ◽  
Epidemiological Data ◽  
Adult Onset ◽  
Global Functioning ◽  
Community Based ◽  
Axis I Disorders ◽  
Significant Impairment ◽  
Axis I

BackgroundLittle is currently known about functioning and impairment during adulthood associated with the course of personality disorders.AimsTo investigate the association of personality disorder stability from adolescence through middle adulthood with measures of global functioning and impairment, using prospective epidemiological data.MethodA community-based sample of 658 individuals was interviewed at mean ages 14, 16, 22 and 33 years.ResultsIndividuals with persistent personality disorder had markedly poorer functioning and greater impairment at mean age 33 years than did those who had never been identified as having such disorder or who had a personality disorder that was in remission, after co-occurring Axis I disorders at age 33 years were taken into account. Remitted disorder was associated with mild long-term impairment. Adult-onset personality disorders, however, were also associated with significant impairment.ConclusionsPersistent and adult-onset personality disorders are associated with functional impairment among adults in the community. These effects are independent of co-occurring Axis 1 disorders.

Systematic review of psychotherapeutic treatments for “minor” personality disorders

2011 ◽  
Vol 26 (S2) ◽  
pp. 2106-2106
Author(s):  
K. Lieb ◽  
J. Stoffers ◽  
B. Völlm
Keyword(s):  
Personality Disorders ◽  
Cochrane Collaboration ◽  
Borderline Personality ◽  
Current Evidence ◽  
Electronic Search ◽  
Literature Searches ◽  
Dsm V ◽  
Axis I Disorders ◽  
Axis I ◽  
Overall Functioning

IntroductionAmong personality disorders (PDs), antisocial and borderline personality disorder are well-studied. However, the remaining PDs (in the following called “minor PDs”) pose major problems in everyday-health care settings. People affected often present with additional axis-I disorders such as substance-related, mood or anxiety disorders, and are among those most difficult to treat.ObjectivesTo systematically review the current evidence of psychotherapeutic treatments for “minor” personality disordersMethodsIn the context of Cochrane Collaboration reviews for Cluster A, B and C PDs, exhaustive literature searches were done to identify the current RCT evidence for PD treatments. The electronic search strategies were extended to identify also non-RCT evidence for minor PD treatments. Retrievals were assessed and evaluated by two reviewers independently.ResultsThe current evidence for psychotherapeutic treatments of minor PDs is sparse and based on mixed PD samples with co-morbid axis-I disorders in the majority of cases. Reported outcomes focus on specific axis-I disorders or general measures such as overall functioning.ConclusionsThe current evidence is scarce and does not allow for distinct treatment recommendations but undermines the importance of meeting special demands of PD patients by PD-specific treatments. Possible reasons for the paucity of research in this regard will be discussed, also in the light of future developments after DSM-V.

Sign in / Sign up

Export Citation Format

Share Document